Dexmedetomidine an Effective Drug in Reducing Anesthetic Requirements in External Dacrocystorhinostomy (DCR) Patients
Dexmedetomidine As an Effective Drug in Reducing Anesthetic Requirements in Patients Undergoing External Dacrocystorhinostomy, a Randomized Controlled Study
Research Institute of Ophthalmology, Egypt
24 participants
Apr 16, 2024
INTERVENTIONAL
Conditions
Summary
Assessing the intra and postoperative hemodynamic stability in patients undergoing external dacrocystorhinostomy under general anesthesia using Dexmedetomidine as a preoperative sedation compared to traditional technique with intraoperative analgesia and assessing decreased anesthetic requirements intra and postoperative
Eligibility
Inclusion Criteria1
- patients of both sexes 16 years to 75 years of age ASA (American society of Anesthesiologists) I-III
Exclusion Criteria2
- Pediatric age group
- ASA more than III
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
drug will be given before induction and anesthetic doses and hemodynamics will be assessed pre- intra and postoperative
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06808295